Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
autoreactive, backlog, Becerra, bevacizumab, bundle, Catalyst, category, caught, censure, Cir, circumstance, closure, Colombia, colorectal, confirm, Connecticut, Cosmetic, covid, daily, deep, deliverable, derecognized, distinct, evolution, excise, fashion, FDORA, forecast, forecasted, image, imvotamab, intermediate, intervene, intervention, longstanding, macroeconomic, margin, met, myasthenia, myasthenic, Overview, PA, pathogenic, peer, preapproval, predominant, predominantly, predominately, proceed, qualitative, quantitative, radiographic, randomized, reassessed, reassessment, receivership, recovery, reevaluate, refund, regained, regime, resilience, revolving, rheumatoid, shortage, Silicon, SLE, spur, SSP, standalone, subset, sunrise, SVB, symptom, thought, trapping, tying, unconditional, unconditionally, uninsured, Unitary, unused, UPC, Utah, Valley, Venezuela, wage
Removed:
advertisement, amounting, bridge, certified, commensurate, computation, degranulation, detail, diagram, diffuse, follicular, formally, formation, GITR, Guggenheim, Guide, Haldor, hematological, Hexavalent, inclusive, indemnification, indemnified, indemnify, induced, induction, Jaffray, lab, LLC, lytic, malignant, marketability, membrane, mg, midpoint, movement, multispecific, multispecificity, noted, outbreak, Penta, percent, perforin, Piper, pore, receivable, retrospective, salt, Schematic, settle, settled, simplify, Simplifying, social, stably, step, Stifel, stopping, studying, television, Treaty, Trump, unrelated, utilized, weighted, Wholesale
Filing tables
Filing exhibits
Associated IGMS transcripts
IGMS similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-268136, 333-258644, 333-258641, and 333-249863 on Form S-3 and Registration Statement Nos. 333-248111, 333-237411, 333-233826, 333-254877, and 333-263927 on Form S-8 of our report dated March 30, 2023, relating to the financial statements of IGM Biosciences, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2022.
/s/ Deloitte & Touche
San Francisco, California
March 30, 2023